材料与化学化工学部学术报告:Nanoparticles for Drug Targeting: Past, Present and Future

报告题目: Nanoparticles for Drug Targeting: Past, Present and Future

: Prof. Gert Storm

1Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands ; 2 Dept. Biomaterials Science & Technology (BST), MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands

报告时间: 2019319星期二上午10:30-11:30

报告地点: 独墅湖校区911号楼401

 

报告摘要: One most active sector of research within the field of nanomedicine has been the design of nanoparticulate pharmaceuticals for targeted drug delivery. In fact, novel and established nanoparticle systems continue to flourish in the research laboratory.  However, the number of such systems that have been approved for the treatment of patients is still limited. Examples are Caelyx/Doxil (doxorubicin), Myocet (doxorubicin), DaunoXome (daunorubicin), Marqibo (vincristine), Onyvide (irinotecan), Onco-TCS (vincristine), Vyxeos (cytarabine and daunorubicin), Abraxane (paclitaxel) and Onpattro (transthyretin-directed siRNA). While these examples illustrate that significant advances have been made over the years in making nanoparticulate nanomedicines a clinical reality, there is nevertheless growing sceptism in the scientific literature regarding the future and clinical applicability of such targeted nanopharmaceuticals. In this presentation, I will discuss the arguments raised to justify this negative attitude as well as my different view on the current status and future of the use of nanoparticles for drug targeting.

 

报告人简介:Gert Storm, professor (Targeted Drug Delivery) at the Department of Pharmaceutics (80% employment), obtained his Ph.D. degree in 1987 at the Utrecht University. In 1988-1989, he was a visiting scientist at Liposome Technology Inc. in Menlo Park, USA, and visiting assistant professor at the School of Pharmacy, UCSF, San Francisco. In 1990-1991, he became senior research scientist at Pharma Bio-Research Consultancy B.V. in Zuidlaren, The Netherlands. During this period he contributed to the design, co-ordination and evaluation of clinical pharmacological studies. In September 1991 he took up his position at the Utrecht University. He is honorary professor (Biomacromolecular Drug Delivery) at the University of Copenhagen. From 2012 on, he is also professor (Targeted Therapeutics) at the MIRA institute of the University of Twente (20% employment). Furthermore, he keeps a position (seconded) at the University Medical Center Utrecht (UMCU) (Division Imaging).

To date, he has co-authored more than 540 publications (h-index >90). The design, characterization and (pre)clinical testing of targeted nanomedicine formulations is the core activity. Additionally, the implementation of imaging-guided drug delivery protocols (using e.g. SPECT, MRI, PET) is a major research objective.

From 2014 on, he is every year included in the lists of The World’s Most Influential Scientific Minds of Thomson Reuters (Highly Cited Researchers) and more recently Clarivate Analytics.

Over the last decade, clinical translation of academic results has become a vital element of Prof. Storm’s ambition, as exemplified by the clinical development of liposomal corticosteroids (by the creation of the spin-off company Enceladus Pharmaceuticals BV in 2005), the clinical breast cancer study at the UMCU evaluating image-guided targeted doxorubicin delivery with hyperthermia (follow-up of the HIFU-CHEM project), his involvement in public-private partnership projects, i.e. EC (coordinator Meditrans (FP6), partnering in 4 FP7 projects and 2 Horizon2020 projects), CTMM (PI HIFU-CHEM), NanoNextNL (director Program Drug Delivery), TI-Pharma and AgentschapNL. Over the years, he also obtained significant funding for applied research from STW and several large industries (e.g. Astellas, Astra Zeneca, Novartis). He is on the Board of the CLINAM (European Foundation for Clinical Nanomedicine) organization in Basel, and the PRC (Phospholipid Research Center) in Heidelberg.

(材料与化学化工学部)
苏大概况 教育教学
院部设置 科学研究
组织机构 合作交流
招生就业 公共服务
Copyright 澳门轮盘游戏网址 2016, All Rights Reserved

苏州市十梓街1号 组织策划:校长办公室

苏ICP备-10229414  苏公网安备 32050802010530号
推荐使用IE8.0以上浏览器,1280*760分辨率访问本网
友情链接:美高梅游戏网址  永利在线排名  澳门皇家赌场  澳门皇家网址  葡京网上赌场注册  永利游戏平台  美高梅娱乐平台  美高梅网投大全  冉冉棋牌  利豪棋牌  威利斯棋牌  华郎棋牌  火爆的棋牌  澳门博彩在线网址  赌博网站开户注册  金沙app网站  澳门网上赌博公司  门名棋牌  麻辣棋牌  web棋牌  红旗棋牌  来宝嬴棋牌  网上娱乐网站排行榜  澳门正规赌博平台  永利网上赌博网站  mg线上娱乐平台网站  永利娱乐在线  葡京网址十大排行  澳门娱乐网上平台  赌博平台  葡京开户平台  最新赌博线上平台  澳门永利手机官网  永利赌博网站  葡京赌博网址排行  澳门网上赌博网址排行  澳门最新赌博网送彩金  博彩导航旗舰站  澳门葡京网址官网网站  美高梅直营开户  澳门永利开户  澳门星际开户官网网址  澳门葡京网址官网  黄金棋牌  澳门银河娱乐场网址官网  新濠天地官网  澳门金沙网上娱乐  澳门金沙娱乐网址官网  澳门金沙娱乐网址  澳门金沙娱乐官网  赌博娱乐场网址  澳门威尼斯人  澳门葡京赌场网址  澳门永利娱乐  澳门赌博娱乐场网站  澳门赌博娱乐场官网  金沙娱乐官网  澳门赌场官方网站  金沙娱乐平台  白小姐特码通  白小姐点解天  白小姐中特网  E路发赌博网址开户  战神赌博官网平台  总统赌博网址  希尔顿赌博网址开户  扎金花规则棋牌心得  龙虎斗技巧娱乐游戏  百乐牌九游戏  网上赌博网站大全  皇冠比分网  澳门美高梅  澳门金沙网上娱乐  澳门金沙线上娱乐网址  澳门威尼斯赌场  澳门永利平台  澳门真人网站  澳门真人网址  澳门轮盘游戏官网  澳门轮盘游戏网址  澳门轮盘游戏网站  澳门轮盘游戏娱乐  澳门轮盘游戏赌场  澳门轮盘游戏平台  澳门牌九游戏官网  澳门牌九游戏网址  澳门牌九游戏网站  澳门牌九游戏娱乐  澳门牌九游戏赌场  澳门牌九游戏博彩  澳门二十一点游戏官网  澳门二十一点游戏网址